IHI
iShares U.S. Medical Devices ETF
iShares US Dow Jones Medical Equipment Index seeks investment results that correspond generally to the price and yield performance of the Dow Jones US Select Medical Equipment Index.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 3.6 B
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Fund sponsor | Barclays Global Fund Advisors |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | May 01, 2006 |
| Assets (mns) | $3,610 |
| Expense ratio | 40 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Quarterly |
| Taxation | 1099 |
| Stock selection | Market Cap |
| Weighting | Market Cap |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ABBOTT LABORATORIES | 16.6 % |
| INTUITIVE SURGICAL INC | 14.9 % |
| BOSTON SCIENTIFIC CORP | 9.7 % |
| BECTON DICKINSON AND CO | 5.1 % |
| RESMED INC | 5.0 % |
| MEDTRONIC PLC | 4.9 % |
| STRYKER CORP | 4.9 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 4.6 % |
| EDWARDS LIFESCIENCES CORP | 4.5 % |
| IDEXX LABORATORIES INC | 4.4 % |
Constituent Breakdown
| Number of holdings | 47 |
| Herfindahl-Hirschman Index | 804 |
| Wgt avg mkt cap (mns) | $111,895 |
| Large cap (>$10bn) | 90.9% |
| Mid cap ($2-10bn) | 6.4% |
| Small cap (<$2bn) | 2.3% |
| Developed mkts. | 99.7% |
| Emerging mkts. | 0.0% |
Country Exposure
 |
UNITED STATES | 91.1 % |
 |
IRELAND | 8.0 % |
 |
BRITAIN | 0.6 % |
Historical Performance
Standardized Performance (as of 01/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -3.3% | -5.8% | 3.7% | 3.6% | 1.6% | 12.1% | -- | 10.6% |
| Dividend Yield | 0.0% | 0.3% | 0.4% | 0.5% | 0.4% | 0.4% | -- | 0.4% |
| Total Returns | -3.3% | -5.5% | 4.2% | 4.1% | 2.0% | 12.5% | -- | 11.0% | Ann. Volatility | 16.5% | 18.7% | 16.6% | 16.7% | 18.7% | 19.6% | -- | 19.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.72 | 54% |
| MSCI EAFE | 0.77 | 46% |
| MSCI Emg Mkts | 0.55 | 28% |
Liquidity Measures
| Avg. volume (000) | 2,351 |
| ADV traded (mns) | $137 |
| Turnover | 3.8% |
| Avg. Bid/Ask (% of price) | 0.02% |
Technical Indicators
| 30d moving avg. (EMA) | $60.81 |
| Relative strength (RSI) | 39 |
| MACD/Signal | -1.11/-0.82 |
| Bollinger Bands (Upper/Lower) | $64.06/$57.37 |
| Short interest (% of AUM) | 1.5% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IHI |
Expenses vs. IHI |
ALTAR Score™ vs. IHI |
|---|---|---|---|---|
| XHE | State Street SPDR S&P Health Care Equipment ETF | 38.1% | -5 bp | -0.8% |
| MDEV | First Trust Indxx Medical Devices ETF | 32.9% | +30 bp | +0.3% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 25.0% | 0 bp | +2.3% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 23.0% | +25 bp | -3.2% |
| HEAL | Global X HealthTech ETF | 22.0% | +10 bp | -5.3% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 21.1% | +35 bp | -3.2% |
| FMED | Fidelity Disruptive Medicine ETF | 19.6% | +10 bp | -5.6% |
| IYH | iShares U.S. Healthcare ETF | 19.1% | 0 bp | +1.6% |
| XLV | The Health Care Select Sector SPDR Fund | 19.0% | -32 bp | +2.3% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 18.8% | +28 bp | -2.2% |
Risk and Returns: IHI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 2/10/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
UNDERWEIGHT
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.
ALTAR Score™
IHI
4.4%
Cat. Avg
5.4%
ALTAR Score™ Calculation
Category Overview
There are 1164 funds in the US Equity category, with an average ALTAR Score™
of 5.4% and a standard deviation of
2.0%. IHI's ALTAR Score™ is approximately
0.5 standard deviations
below
the category average. This places IHI in the 31st percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
IHISELL
U/W
HOLD
O/W
BUY